The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Benefits and Harms of Breast Cancer Screening: A Systematic Review
Abstract
IMPORTANCE: Patients need to consider both benefits and harms of breast cancer screening. OBJECTIVE: To systematically synthesize available evidence on the association of mammographic screening and clinical breast examination (CBE) at different ages and intervals with breast cancer mortality, overdiagnosis, false-positive biopsy findings, life expectancy, and quality-adjusted life expectancy. EVIDENCE REVIEW: We searched PubMed (to March 6, 2014), CINAHL (to September 10, 2013), and PsycINFO (to September 10, 2013) for systematic reviews, randomized clinical trials (RCTs) (with no limit to publication date), and observational and modeling studies published after January 1, 2000, as well as systematic reviews of all study designs. Included studies (7 reviews, 10 RCTs, 72 observational, 1 modeling) provided evidence on the association between screening with mammography, CBE, or both and prespecified critical outcomes among women at average risk of breast cancer (no known genetic susceptibility, family history, previous breast neoplasia, or chest irradiation). We used summary estimates from existing reviews, supplemented by qualitative synthesis of studies not included in those reviews. FINDINGS: Across all ages of women at average risk, pooled estimates of association between mammography screening and mortality reduction after 13 years of follow-up were similar for 3 meta-analyses of clinical trials (UK Independent Panel: relative risk [RR], 0.80 [95% CI, 0.73-0.89]; Canadian Task Force: RR, 0.82 [95% CI, 0.74-0.94]; Cochrane: RR, 0.81 [95% CI, 0.74-0.87]); were greater in a meta-analysis of cohort studies (RR, 0.75 [95% CI, 0.69 to 0.81]); and were comparable in a modeling study (CISNET; median RR equivalent among 7 models, 0.85 [range, 0.77-0.93]). Uncertainty remains about the magnitude of associated mortality reduction in the entire US population, among women 40 to 49 years, and with annual screening compared with biennial screening. There is uncertainty about the magnitude of overdiagnosis associated with different screening strategies, attributable in part to lack of consensus on methods of estimation and the importance of ductal carcinoma in situ in overdiagnosis. For women with a first mammography screening at age 40 years, estimated 10-year cumulative risk of a false-positive biopsy result was higher (7.0% [95% CI, 6.1%-7.8%]) for annual compared with biennial (4.8% [95% CI, 4.4%-5.2%]) screening. Although 10-year probabilities of false-positive biopsy results were similar for women beginning screening at age 50 years, indirect estimates of lifetime probability of false-positive results were lower. Evidence for the relationship between screening and life expectancy and quality-adjusted life expectancy was low in quality. There was no direct evidence for any additional mortality benefit associated with the addition of CBE to mammography, but observational evidence from the United States and Canada suggested an increase in false-positive findings compared with mammography alone, with both studies finding an estimated 55 additional false-positive findings per extra breast cancer detected with the addition of CBE. CONCLUSIONS AND RELEVANCE: For women of all ages at average risk, screening was associated with a reduction in breast cancer mortality of approximately 20%, although there was uncertainty about quantitative estimates of outcomes for different breast cancer screening strategies in the United States. These findings and the related uncertainty should be considered when making recommendations based on judgments about the balance of benefits and harms of breast cancer screening.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Screening for breast cancer with mammography
Gøtzsche, P. C., & Jørgensen, K. J. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001877.pub5 · Cited by 1,869
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Screening for Breast Cancer: An Update for the U.S. Preventive Services Task Force
Nelson, H. D., Tyne, K., Naik, A., Bougatsos, C., Chan, B. K., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00009 · Cited by 1,248
Screening, T. I. U. P. O. B. C., Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., & Wilcox, M. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.177 · Cited by 1,069
Skaane, P., Bandos, A. I., Gullien, R., Eben, E. B., Ekseth, U., Haakenaasen, U., Izadi, M., Jebsen, I. N., Jahr, G., Krager, M., et al. (2013) · Radiology · doi:10.1148/radiol.12121373 · Cited by 1,012
Ciatto, S., Houssami, N., Bernardi, D., Caumo, F., Pellegrini, M., Brunelli, S., Tuttobene, P., Bricolo, P., Fantò, C., Valentini, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70134-7 · Cited by 838
Miller, A. B., Wall, C., Baines, C. J., Sun, P., To, T., & Narod, S. A. (2014) · BMJ · doi:10.1136/bmj.g366 · Cited by 702
Mandelblatt, J. S., Cronin, K. A., Bailey, S., Berry, D. A., de Koning, H. J., Draisma, G., Huang, H., Lee, S. J., Munsell, M., Plevritis, S. K., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-10-200911170-00010 · Cited by 605
Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography
Ernster, V. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1546 · Cited by 582
Tab�r, L., Vitak, B., Chen, H.-H. T., Yen, M.-F., Duffy, S. W., & Smith, R. A. (2001) · Cancer · doi:10.1002/1097-0142(20010501)91:9<1724::aid-cncr1190>3.0.co;2-v · Cited by 560
Effect of Screening Mammography on Breast-Cancer Mortality in Norway
Kalager, M., Zelen, M., Langmark, F., & Adami, H.-O. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000727 · Cited by 526
Broeders, M., Moss, S., Nyström, L., Njor, S., Jonsson, H., Paap, E., Massat, N., Duffy, S., Lynge, E., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012078 · Cited by 489
Systematic Review: The Long-Term Effects of False-Positive Mammograms
Brewer, N. T., Salz, T., & Lillie, S. E. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-7-200704030-00006 · Cited by 455
Duffy, S. W., Tabár, L., Chen, H., Holmqvist, M., Yen, M., Abdsalah, S., Epstein, B., Frodis, E., Ljungberg, E., Hedborg‐Melander, C., et al. (2002) · Cancer · doi:10.1002/cncr.10765 · Cited by 429
Haas, B. M., Kalra, V., Geisel, J., Raghu, M., Durand, M., & Philpotts, L. E. (2013) · Radiology · doi:10.1148/radiol.13130307 · Cited by 419
Hubbard, R. A., Kerlikowske, K., Flowers, C. I., Yankaskas, B. C., Zhu, W., & Miglioretti, D. L. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00004 · Cited by 414
Overdiagnosis in Mammographic Screening for Breast Cancer in Europe: A Literature Review
Puliti, D., Duffy, S. W., Miccinesi, G., De Koning, H., Lynge, E., Zappa, M., & Paci, E. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.012082 · Cited by 407
Hanmer, J., Lawrence, W. F., Anderson, J. P., Kaplan, R. M., & Fryback, D. G. (2006) · Medical Decision Making · doi:10.1177/0272989x06290497 · Cited by 395
14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening
Alexander, F., Anderson, T., Brown, H., Forrest, A., Hepburn, W., Kirkpatrick, A., Muir, B., Prescott, R., & Smith, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07413-3 · Cited by 388
Positive Predictive Value of Screening Mammography by Age and Family History of Breast Cancer
Kerlikowske, K. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510200050031 · Cited by 364
Schousboe, J. T., Kerlikowske, K., Loh, A., & Cummings, S. R. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-1-201107050-00003 · Cited by 317
The Gothenburg Breast Screening Trial
Bjurstam, N., Björneld, L., Warwick, J., Sala, E., Duffy, S. W., Nyström, L., Walker, N., Cahlin, E., Eriksson, O., Hafström, L., et al. (2003) · Cancer · doi:10.1002/cncr.11361 · Cited by 308
Systematic Overview of Cost-Utility Assessments in Oncology
Earle, C. C., Chapman, R. H., Baker, C. S., Bell, C. M., Stone, P. W., Sandberg, E. A., & Neumann, P. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3302 · Cited by 296
Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer
Coldman, A., Phillips, N., Wilson, C., Decker, K., Chiarelli, A. M., Brisson, J., Zhang, B., Payne, J., Doyle, G., & Ahmad, R. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju261 · Cited by 295
Hersch, J., Barratt, A., Jansen, J., Irwig, L., McGeechan, K., Jacklyn, G., Thornton, H., Dhillon, H., Houssami, N., & McCaffery, K. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60123-4 · Cited by 289
The Swedish Organised Service Screening Evaluation Group (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0349 · Cited by 258
Periodic Screening for Breast Cancer: The HIP Randomized Controlled Trial
Shapiro, S. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.27 · Cited by 257
Hellquist, B. N., Duffy, S. W., Abdsaleh, S., Björneld, L., Bordás, P., Tabár, L., Viták, B., Zackrisson, S., Nyström, L., & Jonsson, H. (2011) · Cancer · doi:10.1002/cncr.25650 · Cited by 254
Andersson, I., & Janzon, L. (1997) · JNCI Monographs · doi:10.1093/jncimono/1997.22.63 · Cited by 250
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Bleyer, A., & Welch, H. G. (2013) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e3182978e4a · Cited by 244
Clinical Breast Examination: Preliminary Results from a Cluster Randomized Controlled Trial in India
Sankaranarayanan, R., Ramadas, K., Thara, S., Muwonge, R., Prabhakar, J., Augustine, P., Venugopal, M., Anju, G., & Mathew, B. S. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr304 · Cited by 243
Duffy, S. W., Tabar, L., Olsen, A. H., Vitak, B., Allgood, P. C., Chen, T. H. H., Yen, A. M. F., & Smith, R. A. (2010) · Journal of Medical Screening · doi:10.1258/jms.2009.009094 · Cited by 240
Health related quality of life in different states of breast cancer
Lidgren, M., Wilking, N., Jönsson, B., & Rehnberg, C. (2007) · Quality of Life Research · doi:10.1007/s11136-007-9202-8 · Cited by 224
Consequences of false-positive screening mammograms
Tosteson, A. N. A., Fryback, D. G., Hammond, C. S., Hanna, L. G., Grove, M. R., Brown, M., Wang, Q., Lindfors, K., & Pisano, E. D. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.981 · Cited by 217
Retrospective Cost-effectiveness Analysis of Screening Mammography
Stout, N. K., Rosenberg, M. A., Trentham-Dietz, A., Smith, M. A., Robinson, S. M., & Fryback, D. G. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj210 · Cited by 209
Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy
Kerlikowske, K., Zhu, W., Hubbard, R. A., Geller, B., Dittus, K., Braithwaite, D., Wernli, K. J., Miglioretti, D. L., O’Meara, E. S., & Breast Cancer Surveillance Consortium, F. T. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.307 · Cited by 209
Quantifying the Benefits and Harms of Screening Mammography
Welch, H. G., & Passow, H. J. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.13635 · Cited by 202
Biesheuvel, C., Barratt, A., Howard, K., Houssami, N., & Irwig, L. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70380-7 · Cited by 196
Interpreting Overdiagnosis Estimates in Population-based Mammography Screening
de Gelder, R., Heijnsdijk, E. A. M., van Ravesteyn, N. T., Fracheboud, J., Draisma, G., & de Koning, H. J. (2011) · Epidemiologic Reviews · doi:10.1093/epirev/mxr009 · Cited by 185
Cost-Effectiveness of Digital Mammography Breast Cancer Screening
Tosteson, A. N. A., Stout, N. K., Fryback, D. G., Acharyya, S., Herman, B. A., Hannah, L. G., Pisano, E. D., & for the DMIST Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-1-200801010-00002 · Cited by 183
Nelson, H. D., Tyne, K., Naik, A. M., Bougatsos, C., Chan, B. K. S., Nygren, P., & Humphrey, L. L. (2009) · PubMed Central · doi:10.1059/0003-4819-151-10-200911170-00009 · Cited by 164
Hakama, M., Pukkala, E., HeikkilÄ, M., & Kallio, M. (1997) · BMJ · doi:10.1136/bmj.314.7084.864 · Cited by 161
Modern mammography screening and breast cancer mortality: population study
Weedon‐Fekjær, H., Romundstad, P., & VATTEN, L. J. (2014) · BMJ · doi:10.1136/bmj.g3701 · Cited by 161
Update on mammography trends: Comparisons of rates in 2000, 2005, and 2008
Breen, N., Gentleman, J. F., & Schiller, J. S. (2011) · Cancer · doi:10.1002/cncr.25679 · Cited by 155
Lansdorp‐Vogelaar, I., Gulati, R., Mariotto, A. B., Schechter, C. B., de Carvalho, T. M., Knudsen, A. B., van Ravesteyn, N. T., Heijnsdijk, E. A. M., Pabiniak, C. J., van Ballegooijen, M., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-2867 · Cited by 149
Stout, N. K., Lee, S. J., Schechter, C. B., Kerlikowske, K. M., Alagöz, O., Berry, D. A., Buist, D. S. M., Çevik, M., Chisholm, G. B., de Koning, H. J., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju092 · Cited by 144
Etzioni, R., Gulati, R., Mallinger, L., & Mandelblatt, J. S. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00008 · Cited by 139
Decreasing Women's Anxieties After Abnormal Mammograms: A Controlled Trial
Barton, M. B., Morley, D. S., Moore, S., Allen, J. D., Kleinman, K., Emmons, K. M., & Fletcher, S. W. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh083 · Cited by 139
Mammographic Screening and Breast Cancer Mortality: A Case–Control Study and Meta-analysis
Nickson, C., Mason, K., English, D. R., & Kavanagh, A. M. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-0468 · Cited by 128
Estimates of overdiagnosis of invasive breast cancer associated with screening mammography
Morrell, S. L., Barratt, A. L., Irwig, L., Howard, K., Biesheuvel, C., & Armstrong, B. K. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9459-z · Cited by 123
Overdiagnosis in Screening: Is the Increase in Breast Cancer Incidence Rates a Cause for Concern ?
Paci, E., Warwick, J., Falini, P., & Duffy, S. W. (2004) · Journal of Medical Screening · doi:10.1177/096914130301100106 · Cited by 108
Association between Mammography Timing and Measures of Screening Performance in the United States
Yankaskas, B. C., Taplin, S. H., Ichikawa, L., Geller, B. M., Rosenberg, R. D., Carney, P. A., Kerlikowske, K. M., Ballard-Barbash, R. R., Cutter, G., & Barlow, W. E. (2005) · Radiology · doi:10.1148/radiol.2342040048 · Cited by 95
New American Cancer Society Process for Creating Trustworthy Cancer Screening Guidelines
Brawley, O. W., Byers, T., Chen, A., Pignone, M. P., Ransohoff, D. F., Schenk, M., Smith, R. A., Sox, H. C., Thorson, A. G., & Wender, R. C. (2011) · JAMA · doi:10.1001/jama.2011.1800 · Cited by 90
Braithwaite, D., Zhu, W., Hubbard, R. A., O’Meara, E. S., Miglioretti, D. L., Geller, B. M., Dittus, K. L., Moore, D. H., Wernli, K. J., Mandelblatt, J. S., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs645 · Cited by 90
Overdiagnosis in organised mammography screening in Denmark. A comparative study
Jørgensen, K. J., Zahl, P. H., & Gøtzsche, P. C. (2009) · BMC Women s Health · doi:10.1186/1472-6874-9-36 · Cited by 88
Effectiveness of service screening: a case–control study to assess breast cancer mortality reduction
the IMPACT Working Group, Puliti, D., Miccinesi, G., Collina, N., Lisi, V. D., Federico, M., Ferretti, S., Finarelli, A. C., Foca, F., Mangone, L., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604532 · Cited by 85
Oestreicher, N., Lehman, C. D., Seger, D., Buist, D. S. M., & White, E. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.2.01840428 · Cited by 78
Overdiagnosis among women attending a population‐based mammography screening program
Falk, R. S., Hofvind, S. S. H., Skaane, P., & Haldorsen, T. (2013) · International Journal of Cancer · doi:10.1002/ijc.28052 · Cited by 75
Mandelblatt, J. S., Schechter, C. B., Yabroff, K. R., Lawrence, W., Dignam, J. J., Extermann, M., Fox, S., Orosz, G. M., Silliman, R. A., Cullen, J. C., et al. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0116.x · Cited by 74
Lynge, E., Ponti, A., James, T. A., Májek, O., von Euler‐Chelpin, M., Anttila, A., Fitzpatrick, P., Frigerio, A., Kawai, M., Scharpantgen, A., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.08.013 · Cited by 64
Organised mammography screening reduces breast cancer mortality: A cohort study from Finland
Sarkeala, T. M., Heinävaara, S. H., & Anttila, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.23070 · Cited by 61
Hofvind, S. S. H., Lee, C. I., & Elmore, J. G. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2162-x · Cited by 56
Moody‐Ayers, S. Y., Wells, C. K., & Feinstein, A. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.8.1109 · Cited by 56
Chapter 12: A Stochastic Simulation Model of U.S. Breast Cancer Mortality Trends From 1975 to 2000
Plevritis, S. K., Sigal, B. M., Salzman, P., Rosenberg, J., & Glynn, P. W. (2006) · JNCI Monographs · doi:10.1093/jncimonographs/lgj012 · Cited by 50
Jonsson, S. (2000) · Acta Oncologica · doi:10.1080/028418600750013302 · Cited by 49
Weighing the Benefits and Burdens of Mammography Screening Among Women Age 80 Years or Older
Schonberg, M. A., Silliman, R. A., & Marcantonio, E. R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9877 · Cited by 46
Coldman, A. J., & Phillips, N. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.121791 · Cited by 45
Balancing harms and benefits of service mammography screening programs: a cohort study
Puliti, D., Miccinesi, G., Zappa, M., Manneschi, G., Crocetti, E., & Paci, E. (2012) · Breast Cancer Research · doi:10.1186/bcr3090 · Cited by 45
Hellquist, B. N., Duffy, S. W., Nyström, L., & Jönsson, H. (2012) · Journal of Medical Screening · doi:10.1258/jms.2012.011104 · Cited by 37
Johns, L. E., & Moss, S. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0623 · Cited by 37
Screening Clinical Breast Examination: How Often Does It Miss Lethal Breast Cancer?
Fenton, J. J. (2005) · JNCI Monographs · doi:10.1093/jncimonographs/lgi040 · Cited by 32
Bansback, N. J., Harrison, M. J., & Marra, C. A. (2015) · Medical Decision Making · doi:10.1177/0272989x15600708 · Cited by 30
Protection of mammography screening against death from breast cancer in women aged 40–64 years
Norman, S. A., Localio, A. R., Weber, A. L., Coates, R. J., Zhou, L. F., Bernstein, L., Malone, K. E., Marchbanks, P. A., Weiss, L. K., Lee, N. C., et al. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9006-8 · Cited by 29
Lund, E., Mode, N. A., Waaseth, M., & Thalabard, J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-614 · Cited by 23
Impact of Mammography Screening Interval on Breast Cancer Diagnosis by Menopausal Status and BMI
Dittus, K. L., Geller, B. M., Weaver, D. L., Kerlikowske, K. M., Zhu, W., Hubbard, R. A., Braithwaite, D., O’Meara, E. S., & Miglioretti, D. L. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2507-0 · Cited by 19
(1977) · doi:10.1002/1097-0142(197706)39:6<2772::aid-cncr2820390665>3.0.co;2-k
Cited by
A view on drug resistance in cancer
Vasan, N., Baselga, J., & Hyman, D. M. (2019) · Nature · doi:10.1038/s41586-019-1730-1 · Cited by 2,770
Oeffinger, K. C., Fontham, E. T. H., Etzioni, R., Herzig, A., Michaelson, J. S., Shih, Y.-C. T., Walter, L. C., Church, T. R., Flowers, C. R., LaMonte, S. J., et al. (2015) · JAMA · doi:10.1001/jama.2015.12783 · Cited by 1,653
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., & Wender, R. C. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21557 · Cited by 701
Causes of death among cancer patients
Zaorsky, N. G., Churilla, T. M., Egleston, B. L., Fisher, S. G., Ridge, J. A., Horwitz, E. M., & Meyer, J. E. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw604 · Cited by 657
Metadata
- Authors
- Myers, E. R., Moorman, P., Gierisch, J. M., Havrilesky, L. J., Grimm, L. J., Ghate, S., Davidson, B., Mongtomery, R. C., Crowley, M. J., McCrory, D. C., Kendrick, A., & Sanders, G. D.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2015-10-20
- Volume
- 314
- Issue
- 15
- Pages
- 1615
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1938908299
- Cited by
- 637
- References
- 78
- FWCI
- 21.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.